share_log

賽生藥業：根據收購守則規則3.8刊發的公告

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

香港交易所 ·  Apr 1 07:53
Summary by Moomoo AI
賽生藥業控股有限公司於2024年4月1日宣佈，根據其首次公開發售後購股權計劃，於3月31日及4月1日共有800,200份購股權失效。公司目前共有627,646,692已發行股份，以及70,231,812份購股權，其中包括購股權激勵計劃及首次公開發售後購股權計劃下授出的購股權。此外，公司提醒股東及潛在投資者，關於Silver Pegasus Investment Limited提出的私有化建議、計劃及購股權要約仍待條件達成或獲豁免後方可實行，因此存在不確定性。股東及潛在投資者應謹慎行事，並在必要時尋求專業意見。
賽生藥業控股有限公司於2024年4月1日宣佈，根據其首次公開發售後購股權計劃，於3月31日及4月1日共有800,200份購股權失效。公司目前共有627,646,692已發行股份，以及70,231,812份購股權，其中包括購股權激勵計劃及首次公開發售後購股權計劃下授出的購股權。此外，公司提醒股東及潛在投資者，關於Silver Pegasus Investment Limited提出的私有化建議、計劃及購股權要約仍待條件達成或獲豁免後方可實行，因此存在不確定性。股東及潛在投資者應謹慎行事，並在必要時尋求專業意見。
SESONG PHARMACEUTICAL HOLDINGS LIMITED ANNOUNCED ON APRIL 1, 2024 THAT A TOTAL OF 800,200 SHARE OPTIONS UNDER ITS INITIAL PUBLIC OFFERING POST-SALE SHARE OPTION PLAN EXPIRED ON MARCH 31 AND APRIL 1. The Company currently has 627,646,692 shares issued and 70,231,812 share options, including warrants granted under the Share Option Incentive Scheme and the Initial Public Offering Possession Option Scheme. In addition, the Company reminds shareholders and potential investors that there is uncertainty regarding the privatization proposals, plans and share purchase agreements submitted by Silver Pegasus Investment Limited, which remain conditional upon completion or exemption. Shareholders and potential investors should exercise caution and seek professional advice when necessary.
SESONG PHARMACEUTICAL HOLDINGS LIMITED ANNOUNCED ON APRIL 1, 2024 THAT A TOTAL OF 800,200 SHARE OPTIONS UNDER ITS INITIAL PUBLIC OFFERING POST-SALE SHARE OPTION PLAN EXPIRED ON MARCH 31 AND APRIL 1. The Company currently has 627,646,692 shares issued and 70,231,812 share options, including warrants granted under the Share Option Incentive Scheme and the Initial Public Offering Possession Option Scheme. In addition, the Company reminds shareholders and potential investors that there is uncertainty regarding the privatization proposals, plans and share purchase agreements submitted by Silver Pegasus Investment Limited, which remain conditional upon completion or exemption. Shareholders and potential investors should exercise caution and seek professional advice when necessary.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more